Across multiple health campaigns in the Philippines, a recurring message is emerging: persistent, “ordinary” symptoms may carry deeper meaning, and recognizing them early could make a critical difference in health outcomes.
Fatigue often dismissed, but could signal a blood disorder
As the world marked World Blood Cancer Day this May, health experts raised concern over how symptoms such as persistent fatigue, frequent infections, and easy bruising are often overlooked and attributed to aging or burnout.
These symptoms may point to Myelodysplastic Syndromes (MDS), now more accurately referred to as Myelodysplastic Neoplasms, a form of blood cancer affecting bone marrow function. The condition disrupts the production of healthy blood cells, leading to anemia, infections, and bleeding tendencies.
A 10-year study at Makati Medical Center involving 240 patients found that MDS remains “underestimated, underreported, and underdiagnosed” in the Philippines. The same study noted that only 15% of patients received cytogenetic testing, meaning most did not undergo full diagnostic evaluation.
“A good doctor must start by reviewing a patient’s full history and conducting a physical exam, because fatigue is very non-specific and can hide many things,” Dr. Rosalio Torres, founding president of the Philippine College of Hematology and Transfusion Medicine, said.
“Our blood cells have critical functions: red cells carry oxygen, white cells fight infections, and platelets stop us from bleeding. When these are damaged in MDS, patients suffer from shortness of breath, lack of energy, recurrent infections, and easy bruising or bleeding,” he added.
Experts stressed that early consultation, often starting with a Complete Blood Count (CBC), can help detect abnormalities and guide referral to a hematologist for further testing.
“We now have management and supportive care options available in the Philippines. While these treatments are often long-term and can be resource-intensive, catching the disease early helps us manage costs and care more effectively,” Torres said.
Diabetes and obesity framed as chronic diseases needing long-term care
In a separate development, healthcare stakeholders and advocacy groups in the Philippines expanded efforts to address obesity and diabetes through a new partnership between healthcare solutions company Zuellig Pharma and Philippine Diabetes Support (PDS).
The initiative builds on earlier collaborations with medical societies such as PASOO, PCEDM, PHA, ISDFI, Diabetes Philippines, and ACE and aims to strengthen patient education and reduce stigma around metabolic diseases.
The coalition emphasized that obesity should be understood as a chronic condition influenced by “complex medical, genetic, neurological, and environmental factors, and not simply a reflection of lifestyle choices, personal failure, or lack of discipline.”
A public forum held alongside the partnership signing featured discussions on obesity as a chronic disease and the importance of evidence-based treatment pathways, including newer dual GIP and GLP-1 receptor agonists.
Organizers said the effort seeks to align clinical guidance with patient realities, while improving access to long-term, supervised care.
Community-based kidney screening highlights early detection gaps
Meanwhile, Quezon City and Boehringer Ingelheim Philippines launched a community-based initiative aimed at improving early detection of chronic kidney disease (CKD) through barangay-level screening.
The program, titled “Iwas Dialysis, Ligtas Kidneys: Get CheCKD Habang Maaga Pa!”, focuses on early identification of at-risk individuals and timely referral for further evaluation.
Health officials cited estimates that around 13 million Filipinos, or 11.2% of the population, may be living with CKD, many undiagnosed until later stages.
“Protecting QCitizens from chronic kidney disease starts with helping communities recognize the importance of early screening and prevention,” Quezon City Health Officer Dr. Ramona Abarquez said.
She added that early detection is especially important for people with diabetes or hypertension, as symptoms like fatigue and nausea are often overlooked until the disease progresses.
Everyday digestive issues show how symptoms are often generalized
In another health education campaign aligned with World Digestive Health Day, common gastrointestinal complaints were used to highlight how symptoms are often misinterpreted and treated uniformly.
The campaign noted that heartburn, constipation, abdominal cramps, and gut imbalance each have different underlying causes and may require different forms of care, including antacids, laxatives, antispasmodics, and probiotics depending on symptoms.
It also warned that persistent discomfort should not be dismissed as routine, particularly when linked to possible liver-related concerns or ongoing fatigue.
For gut balance concerns, probiotics such as Erceflora were also cited as part of supportive care for maintaining digestive health.
It was stressed that symptom-specific care and proper consultation are more effective than self-medicating based on generalized assumptions.
Health systems and insurers emphasize early intervention and efficiency
On the healthcare systems side, insurer iCare reported its rise to third place among Philippine HMOs, following a broader transformation after its acquisition in 2023 by Singapore-based Value-Based Healthcare.
Company leadership attributed its growth to investments in technology, expanded hospital networks, and workforce scaling.
“Our leap to the top three is a testament to what happens when you combine world-class operational discipline with deeply empathetic, patient-first care,” iCare President and CEO Geronimo Francisco said.
“For us, scale is meaningless without service excellence. Reaching no. 3 is just the beginning,” he added.
The company also highlighted efforts to improve claims processing, service turnaround times, and customer experience systems as part of its healthcare delivery strategy.